Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

Altis's AI Model Outperforms RECIST 1.1 in Predicting Overall Survival These findings showcase IPRO-Δ's potential to accelerate clinical d ...

Envestnet Portfolio Solutions Inc. reduced its stake in shares of Koninklijke Philips (NYSE:PHG – Free Report) by 10.8% ...

This article delves into the theoretical roles of these peptides in brain research and discusses the directions in which they ...

For patients with resected stage IB-IIIA epidermal growth factor receptor-mutated non-small cell lung cancer, molecular ...

A hidden quantum wave may keep particles moving, even when everything else freezes. Researchers discovered that phasons, a ...

(Nasdaq: VCYT), a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...

Marseille, France, March 25, 2025 - Vect-Horus, a privately held biotechnology company that designs and develops molecular vectors facilitating the targeted delivery of therapeutic molecules and ...

Gary A. Ulaner, M.D., Ph.D., F.A.C.N.M. is the director of molecular imaging and therapy at Hoag Family Cancer Institute and ...

Burton Eisenberg, M.D., has spent his career dedicated to improving the lives of cancer patients. Since 2013, he has served as executive medical director of Hoag Family Cancer Institute and is the ...

Phasons, low-temperature quasiparticles found in crystal lattices, help interlayer excitons move at ultra-low temperatures, ...